48,706
edits
(21 intermediate revisions by the same user not shown) | |||
Line 24: | Line 24: | ||
Notes: | Notes: | ||
*There are almost no quality of life differences between total & subtotal hysterectomy.<ref name=pmid12397189>{{Cite journal | last1 = Thakar | first1 = R. | last2 = Ayers | first2 = S. | last3 = Clarkson | first3 = P. | last4 = Stanton | first4 = S. | last5 = Manyonda | first5 = I. | title = Outcomes after total versus subtotal abdominal hysterectomy. | journal = N Engl J Med | volume = 347 | issue = 17 | pages = 1318-25 | month = Oct | year = 2002 | doi = 10.1056/NEJMoa013336 | PMID = 12397189 }}</ref> | *There are almost no quality of life differences between total & subtotal hysterectomy.<ref name=pmid12397189>{{Cite journal | last1 = Thakar | first1 = R. | last2 = Ayers | first2 = S. | last3 = Clarkson | first3 = P. | last4 = Stanton | first4 = S. | last5 = Manyonda | first5 = I. | title = Outcomes after total versus subtotal abdominal hysterectomy. | journal = N Engl J Med | volume = 347 | issue = 17 | pages = 1318-25 | month = Oct | year = 2002 | doi = 10.1056/NEJMoa013336 | PMID = 12397189 }}</ref> | ||
*''Simple hysterectomy'' is removal of the uterus and cervix;<ref>{{Cite journal | last1 = Somashekhar | first1 = SP. | last2 = Ashwin | first2 = KR. | title = Management of Early Stage Cervical Cancer. | journal = Rev Recent Clin Trials | volume = | issue = | pages = | month = Sep | year = 2015 | doi = | PMID = 26411950 }}</ref> it can be used as a synonym for ''total hysterectomy''.<ref>URL: [http://www.baymoon.com/~gyncancer/library/glossary/bldefhyster.htm http://www.baymoon.com/~gyncancer/library/glossary/bldefhyster.htm]. Accessed on: 8 October 2015.</ref> | |||
==Grossing hysterectomy specimens== | |||
*[[Hysterectomy for endometrial cancer grossing]]. | |||
*[[Hysterectomy for endometrial hyperplasia grossing]]. | |||
*[[Hysterectomy for fibroids grossing]]. | |||
===Hysterectomy specimens - orientation=== | |||
Orientation: | |||
*Less peritoneum on anterior (as the [[urinary bladder]] is there). | |||
**'''P'''osterior '''p'''eritoneal edge: '''p'''ointy (upside down triangle). | |||
***Anterior peritoneal edge: rounded/non-pointy. | |||
*Tubes on anterior-lateral aspect.<ref>{{Ref Lester3|425}}</ref> | |||
**Round ligaments posterior to tubes. | |||
=Normal uterine wall= | =Normal uterine wall= | ||
Line 87: | Line 101: | ||
==Uterine adenomyosis== | ==Uterine adenomyosis== | ||
*[[AKA]] ''adenomyosis of the uterus''. | *[[AKA]] ''adenomyosis of the uterus''. | ||
{{Main|Uterine adenomyosis}} | |||
==Uterine prolapse== | ==Uterine prolapse== | ||
:''Urogenital prolapse'' redirects here. | :''Urogenital prolapse'' redirects here. | ||
{{main|Uterine prolapse}} | |||
==Dysfunctional uterine bleeding== | ==Dysfunctional uterine bleeding== | ||
Line 203: | Line 121: | ||
===Sign out=== | ===Sign out=== | ||
<pre> | |||
Uterus, Cervix, and Bilateral Uterine Tubes, Total Hysterectomy and Bilateral Salpingectomy: | |||
- Uterine cervix within normal limits. | |||
- Proliferative phase endometrium with focal fibrosis, compatible with prior ablation. | |||
- Uterine leiomyomas. | |||
- Bilateral uterine tubes without significant pathology. | |||
- NEGATIVE for malignancy. | |||
</pre> | |||
====Block letters==== | |||
<pre> | <pre> | ||
A. OMENTUM, BIOPSY: | A. OMENTUM, BIOPSY: | ||
Line 219: | Line 147: | ||
- BILATERAL UTERINE TUBES WITHOUT SIGNIFICANT PATHOLOGY. | - BILATERAL UTERINE TUBES WITHOUT SIGNIFICANT PATHOLOGY. | ||
- NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR MALIGNANCY. | ||
</pre> | |||
==BRCA carrier== | |||
===General=== | |||
*Prophylatic bilateral salpingo-oophorectomies (BSOs) done in [[BRCA1|BRCA carrier]]s to reduce risk of [[serous carcinoma]].<ref name=pmid27241111>{{Cite journal | last1 = Shaw | first1 = PA. | last2 = Clarke | first2 = BA. | title = Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers. | journal = Surg Pathol Clin | volume = 9 | issue = 2 | pages = 307-28 | month = Jun | year = 2016 | doi = 10.1016/j.path.2016.02.002 | PMID = 27241111 }}</ref> | |||
Incidence of pathology in prophylatic BSOs in a series of 226 cases:<ref name=pmid22710074>{{Cite journal | last1 = Mingels | first1 = MJ. | last2 = Roelofsen | first2 = T. | last3 = van der Laak | first3 = JA. | last4 = de Hullu | first4 = JA. | last5 = van Ham | first5 = MA. | last6 = Massuger | first6 = LF. | last7 = Bulten | first7 = J. | last8 = Bol | first8 = M. | title = Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls. | journal = Gynecol Oncol | volume = 127 | issue = 1 | pages = 88-93 | month = Oct | year = 2012 | doi = 10.1016/j.ygyno.2012.06.015 | PMID = 22710074 }}</ref> | |||
*Invasive carcinoma ~ 0.9%. | |||
*STIC ~ 6.2% | |||
===Grossing=== | |||
*In prophylatic procedures, the ovaries and tubes, endometrium, and lower uterine segment should all be [[submitted in total]].<ref name=pmid24495259>{{Cite journal | last1 = Downes | first1 = MR. | last2 = Allo | first2 = G. | last3 = McCluggage | first3 = WG. | last4 = Sy | first4 = K. | last5 = Ferguson | first5 = SE. | last6 = Aronson | first6 = M. | last7 = Pollett | first7 = A. | last8 = Gallinger | first8 = S. | last9 = Bilbily | first9 = E. | title = Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. | journal = Histopathology | volume = 65 | issue = 2 | pages = 228-39 | month = Aug | year = 2014 | doi = 10.1111/his.12386 | PMID = 24495259 }}</ref> | |||
===Microscopic=== | |||
DDx: | |||
*Early [[serous carcinoma]] of the fallopian tube or ovary. | |||
*[[STIC]]. | |||
===IHC=== | |||
*p53 -ve. | |||
*p16 -ve. | |||
*Ki-67 low. | |||
===Sign out=== | |||
<pre> | |||
Uterus, Cervix, Fallopian Tubes and Ovaries, Total Abdominal Hysterectomy and Bilateral Salpingo-Oophorectomy: | |||
- Uterus with fibrous serosal adhesions. | |||
- Cervix within normal limits. | |||
- Atherosclerosis, moderate. | |||
- Inactive endometrium with cystic changes. | |||
- Uterine adenomyosis. | |||
- Fallopian tubes within normal limits. | |||
- Ovaries with benign cysts. | |||
- NEGATIVE for malignancy. | |||
</pre> | </pre> | ||
edits